Gilead Sciences CFO Andrew Dickinson Files Form 144 to Sell 3,000 Shares
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Proposed Form 144 sale by Officer Andrew Dickinson for 3,000 shares of Gilead Sciences, Inc. ($GILD) valued at approximately $435,870 under a Rule 10b5-1 trading plan adopted on August 29, 2024.
Comprehensive Analysis
Executive Summary
On September 15, 2026, Andrew Dickinson, an Officer at Gilead Sciences, Inc. ($GILD), filed a Form 144 notice proposing the sale of 3,000 common shares with an estimated market value of $435,870.00 (approximately $145.29 per share).
Transaction Details
- Security: Common Stock
- Shares Proposed for Sale: 3,000
- Aggregate Market Value: $435,870.00
- Approximate Sale Date: September 15, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Source of Shares: Performance shares acquired directly from the issuer on January 31, 2024.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
Prior Sales Context
Within the past three months, the reporting person has executed consistent monthly sales under the plan:
- August 17, 2026: 3,000 shares sold for gross proceeds of $415,080.00
- July 15, 2026: 3,000 shares sold for gross proceeds of $389,776.80
Market Impact & Significance
The filing indicates a routine, pre-scheduled liquidation of equity compensation via an established Rule 10b5-1 plan. Relative to Gilead's 1.24 billion shares outstanding, the transaction volume is negligible and carries low market significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.